Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Clinical trial NCT03270059 · RECRUITING

Trial details

NCT number: NCT03270059
Sponsor: OHSU Knight Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Central Nervous System Neoplasm Cranial Nerve Disorder Metastatic Malignant Neoplasm in the Brain

Start date: 2017-10-06
Primary completion: 2027-12-15
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.